Skip to main content
. Author manuscript; available in PMC: 2012 Mar 9.
Published in final edited form as: Vaccine. 2011 Jan 31;29(12):2255–2261. doi: 10.1016/j.vaccine.2011.01.043

Figure 5.

Figure 5

Correlation between anti-AMA1 antibody level and the growth-inhibitory activity in the three populations. The Day 0 (A) and Day 42 (B) data are shown. Because there was no pre-existing immunity to malaria in the U.S. adults on Day 0, the data are not shown in the Figure 5A. The x-axis represents the antibody level of a test IgG in GIA well and the y-axis represents the % inhibition of the sample.